For years, hormone replacement therapy carried a cloud of fear. Many women were told, “Hormones cause breast cancer,” while countless men suffered through symptoms of low testosterone believing it was simply part of getting older.

Today, we know the story is far more nuanced.

Modern research has dramatically changed how healthcare providers view hormone therapy, and many experts believe the fear created by early headlines prevented millions of people from receiving treatment that could have improved their quality of life.

What Is HRT?

Hormone Replacement Therapy (HRT) replaces hormones that naturally decline as women approach menopause.

Depending on your needs, treatment may include:

  • Estrogen
  • Progesterone
  • Testosterone (in carefully selected women)

HRT can help relieve symptoms such as:

  • Hot flashes
  • Night sweats
  • Brain fog
  • Mood changes
  • Anxiety
  • Fatigue
  • Vaginal dryness
  • Pain during intimacy
  • Low libido
  • Poor sleep
  • Joint aches
  • Bone loss

Many women also report improvements in energy, skin health, muscle maintenance, and overall quality of life.

What Is TRT?

Testosterone Replacement Therapy (TRT) is designed for men whose testosterone levels have declined and who have symptoms of testosterone deficiency.

Low testosterone may cause:

  • Fatigue
  • Weight gain
  • Loss of muscle
  • Increased body fat
  • Low sex drive
  • Erectile dysfunction
  • Depression
  • Brain fog
  • Poor concentration
  • Decreased motivation
  • Reduced athletic performance

When medically indicated and carefully monitored, TRT can improve energy, mood, muscle mass, libido, bone density, and overall well-being.

Men vs. Women: How Hormones Affect the Body

Women

Women’s hormone levels begin changing during perimenopause, which commonly starts in the early to mid-40s, although some women notice symptoms even earlier.

As estrogen declines, women often experience:

  • Hot flashes
  • Weight gain around the abdomen
  • Mood swings
  • Sleep disturbances
  • Reduced bone density
  • Memory concerns
  • Skin changes

Men

Men experience a gradual decline in testosterone beginning around age 30.

Unlike menopause, this decline is usually slow.

Symptoms may include:

  • Lower energy
  • Reduced strength
  • Difficulty building muscle
  • Increased belly fat
  • Low libido
  • Mood changes

Not every man needs TRT. Treatment is recommended only for men with both symptoms and consistently low testosterone confirmed by laboratory testing.

When Should You Consider Hormone Therapy?

There is no magic age.

Instead, treatment should be based on symptoms, medical history, and laboratory evaluation.

Women

Many experts recommend evaluating women during perimenopause or early menopause—often between ages 45 and 60—especially if symptoms affect daily life. Current evidence suggests that beginning hormone therapy before age 60 or within 10 years of menopause generally provides the greatest benefit-to-risk profile for appropriate candidates.

Men

Men experiencing symptoms of low testosterone should have their hormone levels evaluated regardless of age. Treatment should only begin after a comprehensive medical assessment confirms testosterone deficiency.

The Women’s Health Initiative: What Really Happened?

In 2002, the Women’s Health Initiative (WHI) published findings that linked one specific form of combined oral hormone therapy in older postmenopausal women to increased risks of certain health problems.

The media coverage was immediate—and alarming.

Millions of women stopped hormone therapy almost overnight.

Many physicians stopped prescribing it altogether.

Over the following two decades, researchers took a closer look at the data.

They found that:

  • The average participant was 63 years old, much older than the typical woman beginning menopause.
  • Many participants started hormone therapy more than a decade after menopause.
  • The study evaluated hormone formulations that are no longer the most commonly prescribed.
  • Later analyses showed that risks differ substantially based on a woman’s age, the timing of therapy, the hormone formulation, and whether it is taken orally or through the skin.

The New Government Position

In 2025, the U.S. Department of Health and Human Services and the FDA updated hormone therapy labeling, removing class-wide boxed warnings that many experts believed no longer reflected the best available evidence for modern menopausal hormone therapy. The agencies acknowledged that the original warnings were based largely on older WHI data involving an older population and hormone formulations that are less commonly used today.

Current medical organizations emphasize that:

  • Hormone therapy remains the most effective treatmentfor menopausal symptoms.
  • For healthy women younger than 60 or within 10 years of menopause, the benefits often outweigh the risks when treatment is individualized.
  • Therapy should always be tailored to each patient’s medical history and goals.

The Bottom Line

Hormones are not about turning back the clock.

They’re about helping people feel like themselves again.

Whether you’re struggling with menopause, perimenopause, or low testosterone, today’s approach to hormone therapy is safer, more personalized, and backed by decades of additional research that has reshaped our understanding since 2002.

The most important step is not believing myths—it’s having an informed conversation with a healthcare provider experienced in hormone optimization.

At Dharma Wellness Med Spa, we believe patients deserve evidence-based care, individualized treatment plans, and honest conversations about the benefits and risks of hormone therapy. If you’re wondering whether HRT or TRT could be right for you, schedule a consultation with our team and let’s help you take control of your health, vitality, and quality of life.

 

Hormone Therapy (HRT) Information

Testosterone Replacement Therapy (TRT)

Women’s Health Initiative (WHI)

Updated Evidence & WHI Follow-Up

FDA & U.S. Government Updates

Breast Cancer & Hormone Therapy

Additional Peer-Reviewed Resources